Table 4:

Clinical and Toxicological Background Information for Subjects With High Brain Mercury Levels

	Subject 1	Subject 2	Subject 3	Subject 4
Age at Exposure (yrs)	47	8	38	19
Age at Death (yrs)	48	29	38	20
Time between exposure and death	10 months	21 years	12 days	Injections 21 and 16 months pre-mortem
Gender	F	F	F	M
Exposure route	Dermal and possibly inhalation	Oral	Inhalation	Intravenous
Estimated dose	∼1344 mg (∼0.44 ml)	NA	NA	4 ml
Estimated exposure duration	Seconds to a few minutes	Multiple times over 3 months	Minutes to hours, probably once	Injections 21 and 16 months pre-mortem
Chelation treatment	Yes	Yes	No	Yes